Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α

Author: Chintala Sreenivasulu   Tόth Károly   Cao Shousong   Durrani Farukh   Vaughan Mary   Jensen Randy   Rustum Youcef  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.66, Iss.5, 2010-10, pp. : 899-911

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next